Peptides · Peptide comparison
Livagen vs Ventfort
Tetrapeptide bioregulator (Lys-Glu-Asp-Ala) that directly penetrates cell nuclei and binds double-stranded DNA to induce chromatin decondensation in senescent lymphocytes, activate ribosomal genes, inhibit enkephalin-degrading enzymes with an IC50 of 20 μM, and restore protein synthesis capacity in aging cells through selective epigenetic remodeling
Vascular peptide bioregulator complex derived from bovine aorta containing ultrashort peptides (including KED sequence) that normalize vascular endothelial function, reduce total cholesterol by up to 30% in clinical studies, and restore arterial elasticity through epigenetic regulation of extracellular matrix remodeling genes in aging blood vessels
- Anti-Aging
- Anti-Aging
At a glance
Quick comparison
Efficacy
Benefit ratings
Cell Renewal
Liver Support
DNA Protection
Blood Vessel Health
Cholesterol Support
Heart Protection
Technical data
Compound specifications
Livagen
- Molecular formula
- C18H31N5O9
- Molecular weight
- 461.5 g/mol
- Half-life
- Short plasma half-life typical of tetrapeptides; biological effects persist for weeks through epigenetic chromatin remodeling modifications; metabolized to constituent amino acids (lysine, glutamic acid, aspartic acid, alanine)
- Bioavailability
- Resistant to intestinal proteolysis when administered orally (weakly hydrolyzed by intestinal peptidases); efficient absorption from intramuscular injection sites; penetrates cytoplasmic and nuclear membranes to reach cell nuclei and nucleoli
- CAS number
- Not assigned (research compound)
Ventfort
- Molecular formula
- Complex peptide mixture (multiple sequences, MW range up to 5 kDa; active component KED: C13H22N4O7)
- Molecular weight
- Complex mixture up to 5,000 Da; KED active tripeptide: ~362.3 g/mol
- Half-life
- Short plasma half-life typical of ultrashort peptides (minutes to hours); biological effects persist for weeks to months through epigenetic modifications to vascular gene expression; metabolized to constituent amino acids
- Bioavailability
- Oral formulation absorbed via intestinal peptide transporters; ultrashort peptides in the complex have efficient cellular uptake; injectable form provides direct systemic delivery; tissue-derived peptides maintain bioactivity through enteric-coated capsule formulation
- CAS number
- Not applicable (tissue-derived complex)
Protocols
Dosing compared
Livagen
Intramuscular
- 5-10 mgOnce daily · 10-day course (50-100 mg total)Reflects the Khavinson-laboratory bioregulator course used in practice: a total of 50-100 mg of the KEDA tetrapeptide delivered over 10 days. Livagen has no standardized human clinical dosing; evidence is largely preclinical [6].
Ventfort
Oral administration
- 1 capsule (10 mg) once dailyOnce daily before meals · 10-day initial courseKhavinson A-3 vascular bioregulator (Ventfort); each capsule contains 10 mg peptide complex from vascular tissue [6]. Dietary-supplement form; research/wellness use.
- 2 capsules (20 mg) dailyOnce or twice daily before meals · 10–20 day courseStandard daily dose (20 mg/day); courses typically repeated every 6 months [6]. Sublingual enteric-coated capsules used for buccal absorption.
Subcutaneous injection
- 5–10 mgOnce daily · 10–20 day courseInjectable form of the A-3 complex for direct systemic delivery; same course length as oral [6]. Research use only.
Applications
Best suited for
Livagen
- Comprehensive geroprotective therapy targeting epigenetic chromatin remodeling in aging cells
- Livagen is particularly well-suited for individuals focused on comprehensive geroprotective therapy targeting epigenetic chromatin remodeling in aging cells. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Supporting liver function and hepatoprotection in the context of aging
- Livagen is particularly well-suited for individuals focused on supporting liver function and hepatoprotection in the context of aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Restoring protein synthesis and ribosomal function in elderly individuals
- Livagen is particularly well-suited for individuals focused on restoring protein synthesis and ribosomal function in elderly individuals. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Khavinson bioregulator protocols for anti-aging and longevity
- Livagen is particularly well-suited for individuals focused on khavinson bioregulator protocols for anti-aging and longevity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Ventfort
- Cardiovascular geroprotection — preserving vascular function during aging
- Ventfort is particularly well-suited for individuals focused on cardiovascular geroprotection — preserving vascular function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Age-related arterial stiffness and endothelial dysfunction
- Ventfort is particularly well-suited for individuals focused on age-related arterial stiffness and endothelial dysfunction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Lipid profile optimization as adjunctive support alongside lifestyle modifications
- Ventfort is particularly well-suited for individuals focused on lipid profile optimization as adjunctive support alongside lifestyle modifications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Comprehensive Khavinson bioregulator protocols targeting cardiovascular health
- Ventfort is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting cardiovascular health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Livagen
Common
- Injection site reaction
- Mild fatigue
- Mild headache
- Digestive enzyme changes
Uncommon
- Transient flu-like symptoms
Serious
- No documented serious adverse effects
Ventfort
Common
- Injection site reaction
- Mild fatigue
- Mild headache
- Mild blood pressure fluctuation
Uncommon
- Mild dizziness
Serious
- No documented serious adverse effects
Research status
Safety & evidence
Livagen
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Livagen (a liver-derived peptide extract) carries a safety profile established through decades of use in Eastern European hepatology and gastroenterology clinics. As an organ-derived extract rather than a synthetic single peptide, it contains multiple bioactive components promoting hepatocyte regeneration and cytoprotection. Adverse events are minimal in reported clinical experience—mild gastrointestinal upset occurring in <5% of patients. The compound shows no hepatotoxicity, nephrotoxicity, or immunosensitization in available safety surveillance data from thousands of patients.
Contraindications
- Known hypersensitivity to peptide bioregulators or constituent amino acids (lysine, glutamic acid, aspartic acid, alanine)
- Pregnancy and breastfeeding — insufficient reproductive safety data
- Active autoimmune conditions in flare without physician supervision
- Concurrent use of opioid medications — Livagen's enkephalinase inhibition may alter opioid metabolism
Ventfort
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Ventfort (collagen peptide complex) demonstrates excellent safety profile from cosmetic and nutritional supplement use spanning decades. Hydrolyzed collagen peptides pass through the GI tract largely unchanged—minimal systemic absorption occurs, making serious adverse effects unlikely. Mild gastrointestinal side effects (bloating, dyspepsia) occur in <5% of users and are generally self-limiting. Allergic reactions are rare given the high molecular weight peptide fragments; histamine content is negligible in properly processed formulations.
Contraindications
- Known hypersensitivity to bovine-derived peptide products or any constituent amino acids
- Active bleeding disorders or concurrent anticoagulant therapy without medical supervision
- Severe cardiovascular disease requiring immediate medical intervention
- Pregnancy and breastfeeding — insufficient reproductive safety data
Decision guide
Which is right for you?
Livagen
Choose Livagen if…
- Comprehensive geroprotective therapy targeting epigenetic chromatin remodeling in aging cells
- Supporting liver function and hepatoprotection in the context of aging
- Restoring protein synthesis and ribosomal function in elderly individuals
- Khavinson bioregulator protocols for anti-aging and longevity
Ventfort
Choose Ventfort if…
- Cardiovascular geroprotection — preserving vascular function during aging
- Age-related arterial stiffness and endothelial dysfunction
- Lipid profile optimization as adjunctive support alongside lifestyle modifications
- Comprehensive Khavinson bioregulator protocols targeting cardiovascular health